Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs VICI Properties Inc (VICI) Price & Performance

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade
VICI Properties IncTrade

Price performance (Past 24H)

Key statistics

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs VICI Properties Inc — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.71 (market cap $58.74B), while VICI Properties Inc trades at $22.85 (market cap $25.09B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 2.3× VICI Properties Inc's market cap, and VICI Properties Inc pays the higher dividend (8.07%). Which is the better fit depends on your goals.

TAKVICI
Market Cap
$58.74B$25.09B
Volume
3,110,99417,066,337
Sector
HealthReal Estate
52-Week High
$19.05$31.42
52-Week Low
$13.23$22.53
Typical Hold Time
1 Days—
Enterprise Value
$86.65B$42.65B
Dividend Yield
3.33%8.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

No Aura AI signal available yet.

VICI Properties Inc

VICI Properties trades at $22.83, up 0.84% today, with a bearish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 8.83, net income margin of 67.5%, and robust cash flow from operations of $2.51B in 2025. Recent news highlights dividend coverage strength despite stock price declines, and the company expanded its tenant base with a new lease for Century Mile and Century Downs.

The outlook is mixed: analyst consensus is strongly bullish with a $28.90 price target, but risks include tenant concentration and rising Treasury yields. The stock offers value with a low P/E and high dividend yield, but investors should weigh the bearish technicals and macroeconomic pressures against the solid fundamental performance.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TAK

No sentiment data available yet.

VICI
100% Buy0% Sell

Top news

Latest headlines on both assets

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →

About VICI Properties Inc

VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.

Read more on VICI →